Discontinued — last reported Q3 '22
Investing
Acquisitions
Bristol-Myers Squibb Acquisitions increased by 557.5% to $1.87B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 438.5%, from $348.00M to $1.87B. Over 3 years (FY 2021 to FY 2024), Acquisitions shows an upward trend with a 138.4% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ3 2022
How to read this metric
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
Detailed definition
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Peer comparison
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
Metric ID:
cf_acquisitionsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $366.00M | $1.06B | $152.00M | $442.00M | $467.00M | $3.26B | $116.00M | $78.00M | $184.00M | $326.00M | $581.00M | $20.05B | $1.37B | $348.00M | $47.00M | $78.00M | $285.00M | $1.87B |
| QoQ Change | — | +188.8% | -85.6% | +190.8% | +5.7% | +598.3% | -96.4% | -32.8% | +135.9% | +77.2% | +78.2% | >999% | -93.2% | -74.7% | -86.5% | +66.0% | +265.4% | +557.5% |
| YoY Change | — | — | — | — | +27.6% | +208.5% | -23.7% | -82.4% | -60.6% | -90.0% | +400.9% | >999% | +646.2% | +6.7% | -91.9% | -99.6% | -79.2% | +438.5% |
Range$47.00M – $20.05B
CAGR+46.9%
Avg YoY Growth>999%
Median YoY Growth-8.5%
Current Streak3 quarters growth
Acquisitions at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's acquisitions?
- Bristol-Myers Squibb (BMY) reported acquisitions of $1.87B in Q3 2025.
- How has Bristol-Myers Squibb's acquisitions changed year-over-year?
- Bristol-Myers Squibb's acquisitions increased by 438.5% year-over-year, from $348.00M to $1.87B.
- What is the long-term trend for Bristol-Myers Squibb's acquisitions?
- Over 3 years (2021 to 2024), Bristol-Myers Squibb's acquisitions has grown at a 138.4% compound annual growth rate (CAGR), from $1.61B to $21.82B.
- What does acquisitions mean?
- Cash spent to acquire other companies or businesses, net of cash received in the deal.